NT_1170x120_1-11-18

Humalog 200 units/ml KwikPen

Eli Lilly ships Humalog U-200 KwikPen

Eli Lilly ships Humalog U-200 KwikPen

INDIANAPOLIS — Eli Lilly & Co. has rolled out the Humalog 200 units/ml KwikPen to U.S. pharmacies, calling the medication the nation’s first and only concentrated mealtime insulin analog. Lilly said Tuesday that the Humalog U-200 KwikPen (insulin lispro 200 units/ml) prefilled pen contains a concentrated formulation of the company’s rapid-acting insulin Humalog (insulin lispro 100

Lilly marks a first with Humalog U-200 KwikPen

Lilly marks a first with Humalog U-200 KwikPen

INDIANAPOLIS — Eli Lilly and Co. has been cleared by the Food and Drug Administration to market the Humalog 200 units/ml KwikPen, which the company called the first concentrated mealtime insulin analog approved in the United States. Lilly said Wednesday that the Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml, U-200) is a prefilled pen